---
figid: PMC7859087__fimmu-11-610523-g008
figtitle: FcGR signaling pathway in antibody resistant NLC
organisms:
- Homo sapiens
- Armoracia rusticana
pmcid: PMC7859087
filename: fimmu-11-610523-g008.jpg
figlink: pmc/articles/PMC7859087/figure/f8/
number: F8
caption: Overview of FcγR signaling pathway in antibody resistant NLC. Therapeutic
  antibody binding to cell-surface receptor, FcγR independently activates SYK/BTK
  and p110δ/AKT pathways. Activation of SIRPα by tumor cell CD47 (not shown) activates
  SHP1 phosphatase that suppresses SYK activity.
papertitle: SIRPα Suppresses Response to Therapeutic Antibodies by Nurse Like Cells
  From Chronic Lymphocytic Leukemia Patients.
reftext: Yu-Chen Enya Chen, et al. Front Immunol. 2020;11:610523.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9802859
figid_alias: PMC7859087__F8
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7859087__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7859087__fimmu-11-610523-g008.html
  '@type': Dataset
  description: Overview of FcγR signaling pathway in antibody resistant NLC. Therapeutic
    antibody binding to cell-surface receptor, FcγR independently activates SYK/BTK
    and p110δ/AKT pathways. Activation of SIRPα by tumor cell CD47 (not shown) activates
    SHP1 phosphatase that suppresses SYK activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SIRPA
  - PTPN6
  - NR0B2
  - SYK
  - BTK
  - WDTC1
  - ADP
---
